Thank you for your interest, we’ll get in touch with you shortly!
Edwoak Life Science’s vision is to create a more healthy and sustainable society through innovation and digitization! Welfare actors today have major challenges with reduced financial resources and recruitment of personnel. Because of this, the collaborative work between the actors needs to be made more efficient. Our digital planning and communication tool is there to address this and make a real difference to people’s health and society’s sustainability.
Second Opinion is an AI-based software where the patient can seek a new medical second opinion from an independent doctor or specialist. This makes it possible to identify diagnostic errors and prevent harmful and unnecessary treatments for the patient. A second opinion contributes to an informed and empowered patient who is more involved in their healthcare journey.
Early screening is a major issue with alzheimer disease. Indeed, currently patients often get diagnosed too late, once they have cognitive impairment. As a result, treatments are less efficient and cannot repair the damage already caused by the disease. At Mantis Photonics, we have developed a patented hyperspectral camera that can detect biomarkers of alzheimer in the retina. This will be used as a non-invasive early detection tool for the screening of the population.
Bio-Me is transforming microbiome analysis by making it possible to analyze hundreds of samples in less than a day, with high resolution and reproducibility and at an affordable cost. Combined with an exclusive biobank and extensive patient database, Bio-Me’s Precision Microbiome Profiling platform (PMP™) enables the development of clinical tests that will improve health and well-being worldwide.